It is being reported that the Food and Drug Administration has approved the drug Nexium for children between 1 and 11 years of age who have acid reflux disease.
The drug, made by AstraZeneca is approved in 10 milligrams or 20 milligram doses and is approved in larger doses for kids between 12 and 17 years of age.
Nexium is the second leading selling drug for the company, and is the second most prescribed drug in the world.
“This approval provides important information for appropriate dosing for children ages 1-11 years with GERD,” said Julie Beitz, M.D., director of the FDA’s Office of Drug Evaluation III in the Center for Drug Evaluation and Research. “Children prescribed this drug should be monitored by their physicians for any adverse drug reactions.”
The drug belongs to a class of drugs called proton pump inhibitors that work by decreasing the quantity of acid produced in the stomach.